These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 19890998)
21. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Fernandez HH; Trieschmann ME; Burke MA; Jacques C; Friedman JH Mov Disord; 2003 May; 18(5):510-4. PubMed ID: 12722164 [TBL] [Abstract][Full Text] [Related]
22. Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine. Himmerich H; Ehrlinger M; Hackenberg M; Löhr B; Nickel T J Clin Psychopharmacol; 2006 Dec; 26(6):676-7. PubMed ID: 17110835 [No Abstract] [Full Text] [Related]
23. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Seedat S; Kesler S; Niehaus DJ; Stein DJ Depress Anxiety; 2000; 11(4):185-6. PubMed ID: 10945141 [TBL] [Abstract][Full Text] [Related]
24. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease]. Giménez-Roldán S; Navarro E; Mateo D Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589 [TBL] [Abstract][Full Text] [Related]
26. Neuroleptic malignant syndrome with use of quetiapine in mental retardation. Dan A; Bharadwaj R; Grover S Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404 [No Abstract] [Full Text] [Related]
27. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
28. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease. Parsa MA; Bastani B J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412 [TBL] [Abstract][Full Text] [Related]
30. Use of quetiapine in elderly patients. Tariot PN; Ismail MS J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143 [TBL] [Abstract][Full Text] [Related]
31. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W; Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587 [TBL] [Abstract][Full Text] [Related]
33. Quetiapine in combination with citalopram in patients with unipolar psychotic depression. Konstantinidis A; Hrubos W; Nirnberger G; Windhager E; Lehofer M; Aschauer H; Kasper S Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):242-7. PubMed ID: 16962224 [TBL] [Abstract][Full Text] [Related]
34. [Quetiapine in the treatment of acute mania]. Bräunig P Psychiatr Prax; 2006 Mar; 33 Suppl 1():S27-31. PubMed ID: 16511728 [TBL] [Abstract][Full Text] [Related]
35. Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease. Miwa H; Morita S; Nakanishi I; Kondo T Parkinsonism Relat Disord; 2004 Mar; 10(3):177-80. PubMed ID: 15036174 [TBL] [Abstract][Full Text] [Related]
36. Very low dose quetiapine-induced galactorrhea in combination with venlafaxine. Pae CU; Kim JJ; Lee CU; Chae JH; Lee SJ; Lee C; Paik IH Hum Psychopharmacol; 2004 Aug; 19(6):433-4. PubMed ID: 15303249 [No Abstract] [Full Text] [Related]
37. New medication recommended for Parkinson's disease. Levenson D Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):7-9. PubMed ID: 12182172 [No Abstract] [Full Text] [Related]
38. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275 [TBL] [Abstract][Full Text] [Related]
39. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Keller R; Mongini F Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680 [TBL] [Abstract][Full Text] [Related]